Skin-marking compositions and devices, and their use
First Claim
1. In a diagnostic or therapeutic procedure repeatedly involving a same area of the skin, which occurs at intervals of from 1 to about 21 days and wherein an area of the skin of a patient is marked to delineate the area of the skin involved in the procedure, the improvement comprising marking the skin with a fluorogenically-effective amount, in a carrier liquid, of a furanone of the formula ##STR7## wherein R1 is lower alkoxy or phenyl lower alkoxy and R2 is ##STR8## or, R1 and R2 collectively are ##STR9## wherein R in each instance is hydrogen or one or more of halogen, lower alkyl, trifluoromethyl, lower alkoxy, nitrol, cyano, carboxy or carboxy lower alkyl, and R3 is lower alkyl, phenyl lower alkyl or aryl, thereby rendering the marked area visible under ultraviolet light after about 15-30 minutes and thereafter identifying the marked area by examination of the skin under ultraviolet light, whereby the patient may wash the marked area and avoid the embarrassment of visibly marked skin during the time period between procedures.
0 Assignments
0 Petitions
Accused Products
Abstract
Fluorescamine or like compounds react with the epidermis when applied to the skin and form, within about 15 to 30 minutes after application to the skin, a long-lasting reaction product, which is invisible in ordinary light but which fluoresces intensely under ultraviolet light. Such markings resist removal by abrasion and repeated washings. Organic solutions of such compounds, perferably containing a fugitive dyestuff or pigment and used as the marking fluid of a conventional felt-tipped pen, can be used to mark skin for radiological or diagnostic purposes. Inanimate objects can be coated with these compounds to detect human contact therewith.
30 Citations
4 Claims
- 1. In a diagnostic or therapeutic procedure repeatedly involving a same area of the skin, which occurs at intervals of from 1 to about 21 days and wherein an area of the skin of a patient is marked to delineate the area of the skin involved in the procedure, the improvement comprising marking the skin with a fluorogenically-effective amount, in a carrier liquid, of a furanone of the formula ##STR7## wherein R1 is lower alkoxy or phenyl lower alkoxy and R2 is ##STR8## or, R1 and R2 collectively are ##STR9## wherein R in each instance is hydrogen or one or more of halogen, lower alkyl, trifluoromethyl, lower alkoxy, nitrol, cyano, carboxy or carboxy lower alkyl, and R3 is lower alkyl, phenyl lower alkyl or aryl, thereby rendering the marked area visible under ultraviolet light after about 15-30 minutes and thereafter identifying the marked area by examination of the skin under ultraviolet light, whereby the patient may wash the marked area and avoid the embarrassment of visibly marked skin during the time period between procedures.
Specification